Immunotherapy leverages the body's immune system to fight cancer, but its success depends on the cancer's ability to elicit an immune response. Some cancers have mechanisms to evade the immune system, rendering immunotherapy less effective. For instance, checkpoint inhibitors are effective in cancers like melanoma but show limited success in others due to the lack of immune checkpoint proteins.
